Stock screenerAll disclosures → EDGAR →
CURX
Conviction 80HealthcareScan · Tue, Sep 8, 2026Shooting star
CURX$5.35+5.84%
ResistanceSupportVol 14Vol MA14 166.92K
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price5.35
Change+5.84%
Gap+0.89%
Rel volume1.21×
Avg volume172.07K
Avg $ vol165.43K
SMA 203.16
SMA 501.39
SMA 2000.6339
Price vs 50+283.80%
Price vs 200+743.17%
MA stackbullish
50/200 cross—
Supertrendup · 4.02
RSI (14)83
MACD hist0.10
MACD cross—
Stoch %K / %D82 / 81
ADX (14)56
+DI / −DI62 / 7
RSI divergence—
MACD divergence—
ATR %+9.55%
ADR %11.47%
52w high9.16
52w low0.1830
From 52w high-41.65%
Above 52w low+2820.77%
New 52w highNo
SqueezeOff
Bollinger width274.35%
%B0.75
Donchian pos81.95%
Donchian high6.48
Donchian low0.1923
AVWAP (52w high)0.8799
vs AVWAP high+507.43%
AVWAP (52w low)0.7536
vs AVWAP low+609.23%
OBV trendUp
Chaikin MF (20)0.25
Today vs 20d1.21×
Avg vol (14d)166.92K
Avg vol (20d)172.07K
Avg $ vol (20d)165.43K
Market cap167.64M
RS 3m (vs SPY)+1562.24%
RS 6m (vs SPY)+1180.32%
RS line new highNo
Trend template7/8
Technical rank99.6
1 week+24.30%
1 month+2641.03%
3 months+1650.74%
6 months+1306.21%
1 year-26.07%
YTD+1351.26%
P/E-39.68
P/B35.02
P/S—
P/FCF—
EPS-0.1700
Div yield—
ROE-88.25%
ROA-83.27%
Debt/Eq—
Current45.95
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-1068.75%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value164.71M
Revenue—
Net income-3.29M
Gross profit—
Free cash flow—
IndustryPharmaceutical Preparations
ExchangeNasdaq
Shares out28.36M
Employees6
ListedTue, Aug 26, 2025
Free float9.11M
Float %32.2%
Short interest24.38K
Days to cover0.2d
Short volume59.8%
Squeeze score18 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank99.6 / 100
Group rank—
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmShooting star
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Curanex Pharmaceuticals Inc: Material event (8-K)SEC EDGAR · Fri, Sep 4, 2026
Congress activity
Disclosed STOCK Act trades in CURX
No recent disclosed trades by Congress in CURX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CURX
No recent insider (Form 4) filings in CURX. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in CURX · 4 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.